RCT: Alveolar Ridge Preservation by Socket Seal Techniques

Sponsor
Aristotle University Of Thessaloniki (Other)
Overall Status
Recruiting
CT.gov ID
NCT05577663
Collaborator
University Paul Sabatier of Toulouse (Other)
36
1
3
24
1.5

Study Details

Study Description

Brief Summary

Following tooth extraction, volumetric changes in the soft and hard tissues of the extraction site are expected to occur with considerable resorption of the alveolar bone in both the vertical and the horizontal dimensions. These changes may complicate surgical implant placement and may also compromise the outcome of the prosthetic reconstruction. Various treatment approaches have been introduced aiming to preserve the dimensions of the alveolar ridge at the extraction site and facilitate optimal implant placement.

This prospective randomized controlled trial aims to determine the efficacy of alveolar ridge preservation utilizing two different socket seal approaches compared to spontaneous healing to stabilize the blood clot within the postextraction socket. Thirty-six subjects will be randomly allocated into one of the three treatment groups. Group-A: Extraction of the tooth and suturing of the extraction socket with resorbable suture PGA 5/0. Group-B: Extraction of the tooth and placement of a Free Gingival Graft stabilized with resorbable suture PGA 5/0. Group-C: Extraction of the tooth and placement of the Polylactic-Glycolic Acid membrane stabilized with resorbable suture PGA 5/0. After the initial examination for screening, subjects will be assessed at baseline-extraction day- and after 1, 2, and 6 weeks, and 3 months. The changes of the alveolar crest will be determined in height and width, in addition to volumetric changes in the soft tissues, and the width of keratinized tissues. The wound healing process will be visually assessed.

Condition or Disease Intervention/Treatment Phase
  • Other: Routine treatment of the extraction socket
  • Procedure: Socket seal technique by a free gingival graft
  • Procedure: Socket seal technique using a synthetic resorbable membrane
N/A

Detailed Description

This prospective randomized controlled trial aims to determine the effectiveness of two different approaches of the "socket seal technique" for the preservation of the soft and hard tissues at the extraction site by utilizing a free gingival graft (FGG) or a PLGA membrane to stabilize the blood clot within the extraction socket compared with spontaneous healing of the tissues.

Primary outcome variable of the study will be osseous changes in height and width of the alveolar ridge.

Secondary outcome variables: Mucosa thickness changes, Wound healing visual assessment, Width of keratinized tissues.

Materials and methods Thirty-six subjects will be randomly allocated into one of the three treatment groups based on computer-generated lists using a "block-design". Each patient contributes with one study site.

Study groups:

Group-A: Extraction of the tooth and suturing of the extraction socket with resorbable suture PGA 5/0.

Group-B: Extraction of the tooth, deepithelialization of the gingival colar of the socket, placement of a Free Gingival Graft taken from a standardized location of the palate adjusted to seal the socket opening and then stabilize it by resorbable suture PGA 5/0.

Group-C: Extraction of the tooth, retractio of mucoperiosteal flaps by 2 mm at the opening of the socket using a microsurgical elevator followed by adjustment of the Polylactic-Glycolic Acid membrane over the socket opening resting by 1 mm over the alveolar crest of the extraction socket. Tissues are sutured over the barrier by resorbable suture PGA 5/0.

Timeline of the study/Clinical procedures:

First visit - initial examination - (1 week before the surgery)

  • Suitability of subjects

  • Consent form; Randomization of the patient

  • Radiographic examination (Long-cone paralleling technique using a digital sensor attached to a custom-made silicone bite block for reproducible radiographs)

  • Intra-oral photography

  • Impression of the examined area in order to create a reference stent to reproduce in a standard manner the clinical/radiographic measurements.

  • Full mouth scaling; oral hygiene instructions

Second visit - Baseline - T0

  • Clinical measurements with the use of the reference stent of:

(i) The width of keratinized tissues with the use of a periodontal probe (Hu-Friedy XP-23/QW) (ii) The thickness of mucosa with the use of an ultrasonic device SDM (iii) The width of the alveolar ridge with a dental caliper.

  • Extraction of the tooth in a standardized way to minimize trauma; Post-surgical instructions will be given to the patient. Treatment of the extraction site accordingly to randomized treatment approach (Group-A, -B, -C).

(i) Radiographic examination: (ii) Standardized intraoral x-ray and standardized CBCT (with the use of a reference stent)

Third visit - T1 - (1 week after the surgery)

  • Evidence of healing

  • Intra-oral photography

Fourth visit - T2 - (2 weeks after the surgery)

  • Evidence of healing

  • Removal of sutures

  • Intra-oral photography

Fifth visit - T3 - Re-evaluation (6 weeks after the surgery)

  • Intra-oral photography

  • Width of keratinized tissues with the use of periodontal probe (Hu-Friedy XP-23/QW)

  • Thickness of mucosa determined by the ultrasonic device SDM in the aforementioned standardized points with the use of the reference stent.

  • Clinical record of the width of the alveolar ridge with a dental caliper in the aforementioned standardized points with the use of the reference stent.

  • Radiographic examination (The long-cone paralleling technique will be used at a distance of 10 cm between the X-ray head and the digital sensor which is attached to a custom-made silicone bite block for reproducible radiographs.)

Sixth visit - T4 - Final evaluation (3 months after the extraction)

  • Intra-oral photography

  • Record of periodontal plaque index (Pl) and bleeding on probing (BoP) at the adjacent teeth with the use of periodontal probe (Hu-Friedy XP-23/QW).

  • Record of the width of keratinized tissues with the use of periodontal probe (Hu-Friedy XP-23/QW) and the thickness with the use of the ultrasonic device SDM in the aforementioned standardized points with the use of the reference stent.

  • Clinical record of the width of the alveolar ridge with a dental caliper in the aforementioned standardized points with the use of the reference stent.

  • Radiographic check with standardized intraoral x-ray and CBCT (with the use of the reference stent)

Study Design

Study Type:
Interventional
Anticipated Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomised controlled clinical trial having 3 parallel intervention arms for alveolar ridge preservation and prevention of future alveolar bone resorption due to volumetric changes of tissues post-tooth extraction.Randomised controlled clinical trial having 3 parallel intervention arms for alveolar ridge preservation and prevention of future alveolar bone resorption due to volumetric changes of tissues post-tooth extraction.
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
Treatment is disclosed to the examiner after all data have been collected; investigator and care provider are different individuals.
Primary Purpose:
Treatment
Official Title:
Socket Seal Techniques Employed in Alveolar Ridge Preservation Versus Spontaneous Healing. A Randomized Controlled Trial
Actual Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Spontaneous healing

Routine treatment of the extraction socket. Extraction of the tooth and suturing of the extraction socket with resorbable suture PGA 5/0 (polygalactic acid 5/0 sutures; PGA, medipac, Greece).

Other: Routine treatment of the extraction socket
Suturing of the extraction socket with resorbable suture PGA 5/0 in order to protect the blood clot

Active Comparator: Free gingival graft

Extraction of the tooth, placement of a Free Gingival Graft taken from the palate and adjusted to seal the socket opening and stabilize it by resorbable sutures PGA 5/0 (polygalactic acid 5/0 sutures; PGA, medipac, Greece).

Procedure: Socket seal technique by a free gingival graft
Placement of a free gingival graft in the socket opening in order to protect and stabilize the blood clot followed by suturing

Experimental: Polylactic-Glycolic Acid membrane

Extraction of the tooth, adjustment of the Polylactic-Glycolic Acid membrane (PLGA,TisseosĀ®, Biomedical Tissues, Septodont, France) over the socket opening resting by 1 mm over the alveolar crest of the extraction socket. Tissues are sutured over the barrier by resorbable sutures PGA 5/0 (polygalactic acid 5/0 sutures; PGA, medipac, Greece).

Procedure: Socket seal technique using a synthetic resorbable membrane
Placement of a synthetic barrier in the socket opening in order to protect and stabilize the blood clot followed by suturing

Outcome Measures

Primary Outcome Measures

  1. Osseous changes in width of the alveolar ridge [Clinically: immediately after tooth extraction(baseline), 6 weeks and 3 months after the extraction. CBCT: immediately after the extraction and 3 months after the extraction]

    The width of the alveolar ridge will be measured at standardized points determined by a reference stent with a curved implant caliper. From these measurements the thickness of the soft tissues will be subtracted to determine the width of the alveolar ridge. It will also be measured radiographically with a CBCT

  2. Osseous changes in height of the alveolar ridge [Immediately after the extraction(baseline) and 3 months after the extraction]

    The height of the alveolar ridge will be measured distal, mesial and buccal/ palatal/ lingual at standardized points with the use of a reference stent with a CBCT and then after 3 months by a CBCT.

Secondary Outcome Measures

  1. Mucosa thickness changes [Baseline, 6 weeks and 3 months after the extraction]

    The thickness of the keratinized tissues will be determined with the use of an ultrasonic device SDM (Austenal Medizintechnik, Koln, Germany) for recording soft tissue thickness at standardized points with the use of a reference stent.

  2. Width of keratinized tissues [Baseline, 6 weeks and 3 months after the extraction]

    The width of the keratinized tissues will be determined on the buccal aspect by a manual periodontal probe (Hu-Friedy XP-23/QW) in a standardized way by the use of a reference stent at three time-points. All recordings will be transferred to a digital caliber

  3. Wound healing [1 and 2 weeks after the extraction]

    Visual assessment of healing

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Referrals for a single tooth extraction

  • Periodontal destruction less than 50% of tooth support

  • Signed inform consent form

Exclusion Criteria:
  • Systematic diseases, contradicting surgical procedures and compromise wound healing (i.e. uncontrolled diabetes)

  • Medication that interferes with bone metabolism

  • Pregnancy or lactation

  • Multiple extractions

  • Absence of adjacent teeth

  • Loss of buccal bone, either due to periodontal disease or because of traumatic extraction

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dental School, Aristotle University, Dept of Preventive Dentistry, Periodontology and Implant Biology Thessaloniki Greece 54124

Sponsors and Collaborators

  • Aristotle University Of Thessaloniki
  • University Paul Sabatier of Toulouse

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Danae A. Apatzidou, Associate Professor, Aristotle University Of Thessaloniki
ClinicalTrials.gov Identifier:
NCT05577663
Other Study ID Numbers:
  • AUTh-79/13-02-2020
First Posted:
Oct 13, 2022
Last Update Posted:
Oct 20, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Danae A. Apatzidou, Associate Professor, Aristotle University Of Thessaloniki
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 20, 2022